Goldline Pharmaceutical IPO Allotment Status
Check Goldline Pharmaceutical Allotment Status by PAN
Enter the PAN you applied with — the result comes straight from Bigshare Services Pvt. Ltd..
Not getting a result here? You can also check Goldline Pharmaceutical allotment directly on the Bigshare Services portal →
Check every IPO in one tap
- 1Sign in with Google — no password, free
- 2Save your PAN — and your family's, up to 10
- 3Check any IPO — all saved PANs at once
🔒 PANs are shown masked and can be removed anytime.
Goldline Pharmaceutical IPO — Allotment & Listing Timeline
- IPO Open 12 May 2026
- IPO Close 14 May 2026
- Basis of Allotment 15 May 2026
- Refund Initiation 18 May 2026
- Listing Date 19 May 2026
Goldline Pharmaceutical IPO — Subscription & Allotment Odds
Based on the latest subscription figures for Goldline Pharmaceutical IPO (overall 840.57x subscribed). The more a category is oversubscribed, the lower each applicant's chance of allotment.
In the Retail category, about 1 in 1,000 applicants would get an allotment in Goldline Pharmaceutical IPO. Winners are picked by draw of lots and each gets 6,000 shares (2 lots), so applying for more than the minimum does not improve retail odds.
How Many Goldline Pharmaceutical Retail Applicants Get Shares
Goldline Pharmaceutical set aside 9,00,000 shares for retail (individual) investors. Each successful applicant receives 6,000 shares (2 lots), so the retail quota can serve at most 150 applicants. With retail subscribed 880.68x, that points to roughly 1,15,879 retail applications competing for those allotments.
Estimate from the prospectus reservation and the final subscription; the registrar's Basis of Allotment has the exact count.
Goldline Pharmaceutical IPO Subscription, Day by Day
Times subscribed at the close of each bidding day.
| Day | Retail | NII | QIB | Total |
|---|---|---|---|---|
| Day 1 | 34.07x | 24.46x | 1.31x | 22.35x |
| Day 2 | 139.51x | 146.48x | 1.31x | 100.21x |
| Day 3 | 880.68x | 1,662.35x | 180.22x | 840.57x |
Retail demand grew from 34.07x on day 1 to 880.68x by day 3 — 25.8x over the bidding window.
What Goldline Pharmaceutical Allottees Made on Listing Day
Goldline Pharmaceutical listed at ₹59.75 (+38.95% on the issue price). An applicant allotted 6,000 shares (2 lots) was up about ₹1,00,500 at the listing price, before charges. The last grey market premium we recorded (₹15 on 18 May) pointed to about ₹58; the actual listing was ₹2 higher.
Checking Goldline Pharmaceutical Allotment
Enter the PAN you applied with in the box above; the check goes to Bigshare Services Pvt. Ltd., the registrar for Goldline Pharmaceutical IPO, which finalised the allotment on 15 May 2026.
How the draw of lots works is the same for every issue — see IPO Allotment Process Explained. See all recent IPO allotment results. Last updated: 15 May 2026, 07:38 pm IST.